1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 15th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Recruitment characteristics and non-adherence associated factors of fibromyalgia patients in a randomized clinical trial, 2021, Cardenas-Rojas et al

Discussion in ''Conditions related to ME/CFS' news and research' started by ola_cohn, Dec 3, 2021.

  1. ola_cohn

    ola_cohn Established Member (Voting Rights)

    Messages:
    90
    Location:
    Australia
    Recruitment characteristics and non-adherence associated factors of fibromyalgia patients in a randomized clinical trial: A retrospective survival analysis

    Abstract
    Introduction

    Fibromyalgia is a complex pain condition that affects mostly women. Given the disease's lack of understanding, patients report poor adherence to medication and mistrust of medical services. This study aims to describe the recruitment characteristics and non-adherence associated factors of fibromyalgia patients to an RCT.

    Methods
    We performed a retrospective longitudinal analysis with data from our ongoing RCT. We investigated characteristics of subjects recruited, consented, and randomized. Adherence was studied using survival analysis techniques, and its associated factors were identified using Cox proportional hazards regression model.

    Results
    524 subjects were contacted, 269 were eligible, 61 consented and 40 subjects were randomized. Thirty-eight percent were non-adherent to the protocol with a median of visits of five. The recruitment survey reported that 90% would likely participate in RCTs, 52% had previous participation, and 19% were aware of RCTs by their physicians. Some barriers were investigator-related (staff's friendliness and receiving the results of their trial participation) and center-related (privacy-confidentiality issues and the institution's reputation), without difference between adherent and non-adherent participants. We report significant factors for non-adherence as VAS anxiety score of 5 or more (5.3 HR, p = 0.01), Body Mass Index (BMI) (0.91 HR, p = 0.041) and Quality of Life (QoL) – Personal development subdomain (0.89 HR, p = 0.046).

    Conclusion
    Recruitment and adherence of fibromyalgia patients is a challenge; however, they seem eager to participate in RCTs. We recommend creating a comfortable, friendly and trusting environment to increase the recruitment rate. Higher anxiety, lower BMI and lower quality of life were associated with a higher attrition rate.

    Keywords
    Fibromyalgia, Underrepresented population, Clinical trials participation, Recruitment, Therapeutic adherence and compliance

    Full open text
    https://www.sciencedirect.com/science/article/pii/S2451865421001605?via=ihub
     
    Andy and Peter Trewhitt like this.
  2. rvallee

    rvallee Senior Member (Voting Rights)

    Messages:
    12,454
    Location:
    Canada
    Seems perfectly rational and directly related to the quality of services offered. Why would people adhere to useless treatments? That would be seriously bizarre. It seems to demand an irrational behavior while framing a rational response as faulty.

    Somehow the quality and effectiveness of services offered is never considered as a factor. Even though it's always, and yet again, cited as a main reason by the patients. Which explains why it continues to be. And so it goes... It's good because we do it and we do it because it's good. Science!
     
  3. Milo

    Milo Senior Member (Voting Rights)

    Messages:
    2,108
    So if you’re overweight, female and have FM, you will be further stigmatized.
     
    ola_cohn and Sean like this.

Share This Page